These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 26924059

  • 21. Donor-specific antibodies in a pediatric kidney transplant population-Prevalence and association with antiproliferative drug dosing.
    Strommen AM, Moss MC, Goebel J, Bock M.
    Pediatr Transplant; 2019 Sep; 23(6):e13511. PubMed ID: 31168879
    [Abstract] [Full Text] [Related]

  • 22. Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody.
    Wiebe C, Gibson IW, Blydt-Hansen TD, Pochinco D, Birk PE, Ho J, Karpinski M, Goldberg A, Storsley L, Rush DN, Nickerson PW.
    Am J Transplant; 2015 Nov; 15(11):2921-30. PubMed ID: 26096305
    [Abstract] [Full Text] [Related]

  • 23. Incidence and impact of rejection following simultaneous liver-kidney transplantation.
    Nilles KM, Krupp J, Lapin B, Sustento-Reodica N, Gallon L, Levitsky J.
    J Hepatol; 2015 Feb; 62(2):340-5. PubMed ID: 25195555
    [Abstract] [Full Text] [Related]

  • 24. Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies.
    Ixtlapale-Carmona X, Arvizu A, De-Santiago A, González-Tableros N, López M, Castelán N, Marino LA, Uribe-Uribe NO, Contreras AG, Vilatobá M, Morales-Buenrostro LE, Alberú J.
    Transpl Immunol; 2018 Feb; 46():8-13. PubMed ID: 28974434
    [Abstract] [Full Text] [Related]

  • 25. Rejection in single versus combined pancreas and kidney transplantation in pigs.
    Gruessner RW, Nakhleh R, Tzardis P, Platt JL, Schechner R, Gruessner A, Tomadze G, Matas A, Najarian JS, Sutherland DE.
    Transplantation; 1993 Nov; 56(5):1053-62. PubMed ID: 8249099
    [Abstract] [Full Text] [Related]

  • 26. Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation.
    Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, Stegall MD, Heimbach JK, Taner T.
    Am J Transplant; 2016 Dec; 16(12):3522-3531. PubMed ID: 27184686
    [Abstract] [Full Text] [Related]

  • 27. Acute cellular rejection: impact of donor-specific antibodies and C4d.
    Willicombe M, Roufosse C, Brookes P, McLean AG, Galliford J, Cairns T, Cook TH, Taube D.
    Transplantation; 2014 Feb 27; 97(4):433-9. PubMed ID: 24430742
    [Abstract] [Full Text] [Related]

  • 28. Kidney after liver transplantation does not have an increased risk of rejection compared to liver alone.
    Ghali P, Ibrahim RM, Hodge D, White L, Wadei HM.
    Clin Transplant; 2024 Apr 27; 38(4):e15311. PubMed ID: 38616569
    [Abstract] [Full Text] [Related]

  • 29. Association between longer hospitalization and development of de novo donor specific antibodies in simultaneous liver-kidney transplant recipients.
    Yazawa M, Cseprekal O, Helmick RA, Talwar M, Balaraman V, Podila PSB, Fossey S, Satapathy SK, Eason JD, Molnar MZ.
    Ren Fail; 2020 Nov 27; 42(1):40-47. PubMed ID: 31875761
    [Abstract] [Full Text] [Related]

  • 30. Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches.
    Kwon H, Kim YH, Choi JY, Shin S, Jung JH, Park SK, Han DJ.
    Clin Transplant; 2018 Jun 27; 32(6):e13266. PubMed ID: 29676812
    [Abstract] [Full Text] [Related]

  • 31. Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation.
    Cheng XS, Stedman MR, Chertow GM, Kim WR, Tan JC.
    Transplantation; 2017 May 27; 101(5):1111-1119. PubMed ID: 28437790
    [Abstract] [Full Text] [Related]

  • 32. Combined liver and kidney transplantation in children: analysis of renal graft outcome.
    Ranawaka R, Lloyd C, McKiernan PJ, Hulton SA, Sharif K, Milford DV.
    Pediatr Nephrol; 2016 Sep 27; 31(9):1539-43. PubMed ID: 27105881
    [Abstract] [Full Text] [Related]

  • 33. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
    Pongpirul W, Chancharoenthana W, Pongpirul K, Leelahavanichkul A, Kittikowit W, Jutivorakool K, Nonthasoot B, Avihingsanon Y, Eiam-Ong S, Praditpornsilpa K, Townamchai N.
    Nephrology (Carlton); 2018 Feb 27; 23(2):169-174. PubMed ID: 27888573
    [Abstract] [Full Text] [Related]

  • 34. Examining the Role for Donor-specific Antibody Testing in Simultaneous Liver-kidney Transplantation: A Single-center Analysis of Outcomes.
    Das A, Rocque B, Remulla D, Raza M, Barbetta A, Bangerth S, Goldbeck C, Maw TT, Kim J, Kwon Y, Emamaullee J.
    Transplantation; 2023 May 01; 107(5):1115-1123. PubMed ID: 36398988
    [Abstract] [Full Text] [Related]

  • 35. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S, Watarai Y, Yamamoto T, Tsujita M, Hiramitsu T, Nanmoku K, Goto N, Takeda A, Morozumi K, Katayama A, Saji H, Uchida K, Kobayashi T.
    Hum Immunol; 2013 Sep 01; 74(9):1111-8. PubMed ID: 23792054
    [Abstract] [Full Text] [Related]

  • 36. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
    Lee H, Min JW, Kim JI, Moon IS, Park KH, Yang CW, Chung BH, Oh EJ.
    Medicine (Baltimore); 2016 Mar 01; 95(11):e3094. PubMed ID: 26986147
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the current post-transplantation Human Leukocyte Antigen antibody screening in pediatric renal transplant recipients.
    Demirok A, Ranzijn C, Lardy J, Florquin S, Bouts A.
    Pediatr Transplant; 2019 Mar 01; 23(2):e13338. PubMed ID: 30635959
    [Abstract] [Full Text] [Related]

  • 38. Application and interpretation of histocompatibility data in liver transplantation.
    Wesson RN, Etchill EW, Garonzik-Wang J.
    Curr Opin Organ Transplant; 2017 Oct 01; 22(5):499-504. PubMed ID: 28708813
    [Abstract] [Full Text] [Related]

  • 39. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
    Fidler SJ, Irish AB, Lim W, Ferrari P, Witt CS, Christiansen FT.
    Transpl Immunol; 2013 Jun 01; 28(4):148-53. PubMed ID: 23665534
    [Abstract] [Full Text] [Related]

  • 40. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM, Cecka JM, Millan MT, Salvatierra O.
    Transplantation; 2000 Dec 27; 70(12):1728-36. PubMed ID: 11152105
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.